Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Exp Clin Endocrinol Diabetes ; 122(3): 149-53, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24643691

ABSTRACT

CONTEXT: The supervised 72-h fast remains the gold standard test for the diagnosis of endogenous hyperinsulinism and has recently been suggested to be shortened or even avoided. OBJECTIVE: This study aimed to evaluate whether measurement of blood glucose, insulin and C-peptide levels after a 12 h overnight fast (mini-fasting test), in at least 3 consecutive days, could allow making or ruling out diagnosis of endogenous hyperinsulinism, according to the Endocrine Society's recent guidelines. PATIENTS AND METHODS: We performed 12 h mini-fasting test in at least 3 consecutive days, dosing blood glucose, insulin and C-peptide levels in 26 inpatient patients with pathologically proven endogenous hyperinsulinism. RESULTS: In our series, 100% of patients showed insulin levels of at least 3 µU/ml and C-peptide levels of at least 0.6 ng/ml concomitant with symptomatic hypoglycemia (≤ 55 mg/dl). CONCLUSION: It leads to the conclusion that mini-fasting test might avoid, in most cases, prolonged fasting test for the diagnosis of hypoglycemia due to endogenous hyperinsulinism.


Subject(s)
Blood Glucose/metabolism , C-Peptide/blood , Fasting , Hyperinsulinism/diagnosis , Insulin/blood , Adolescent , Adult , Biomarkers/blood , Child, Preschool , Fasting/blood , Female , Follow-Up Studies , Humans , Hyperinsulinism/blood , Infant , Insulinoma/blood , Insulinoma/metabolism , Male , Middle Aged , Predictive Value of Tests , Treatment Outcome , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL